Client News
InflaRx Announces Commercial Launch of Gohibic (vilobelimab) in the U.S. for the Treatment of Critically Ill COVID-19 Patients
21st June 2023
Mainz Biomed Expands into Romania through Partnership with Bioclinica
20th June 2023
invIOs presents exciting preclinical data showing that immune-activating small molecule INV501 induces strong cytotoxic activity against solid tumors
19th June 2023
Abivax receives “Capital Market Transaction of the Year Award” at the European Mediscience Awards 2023
15th June 2023
Digital health start-up Capreolos GmbH launches Ready4OP app to support patients before major surgical procedures
15th June 2023
Medigene AG: Medigene to Host Virtual R&D Event on TCR-T Therapies for Solid Tumors
13th June 2023
ITM Opens World’s Largest Lutetium-177 Production Facility for Targeted Radionuclide Therapies Against Cancer
13th June 2023
Biotalys Strengthens Relationship with Investors via Private Placement of New Shares for €7 million
7th June 2023
There is no more content to load